 |
 |
||||||||||||||||
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
||||||||
 |
 |
|
|||||||||||||||
 |
|
||||||||||||||||
 |
|
||||||||||||||||
 |
|
||||||||||||||||
 |
|
||||||||||||||||
 |
|
||||||||||||||||
 |
|
||||||||||||||||
| Lipogen and Aker launch joint brain health ingredient |
Brain health ingredient suppliers Lipogen and Aker BioMarine have joined forces to develop a phospholipids formula for use in dietary supplements addressing cognitive health. |
20.5.2010 |
|
||||||||||||||
 |
|
||||||||||||||||
| Lipogen to launch PAS complex for stress. |
Israeli supplier Lipogen is launching proprietary Lipogen PAS in the United States for mental and psychological stress control. |
 |
|
||||||||||||||
 |
|
||||||||||||||||
| Lipogen PS Awarded Patent for Infant Formula. |
The new formulation is based on Lipogen PS, which received
affirmed GRAS status (FDA “no questions”) in 2006. This ready-to-use formulation can be easily applied to any infant formula already containing soy lecithin. |
 |
|
||||||||||||||
 |
|
||||||||||||||||
| FDA gives GRAS go-ahead to Lipogen PS |
Israeli phosphatidylserine-maker Lipogen now has FDA affirmed GRAS status for its patented product line, suggesting increasing US market interest in this mental health ingredient. |
 |
|
||||||||||||||
 |
|
||||||||||||||||
| Lipogen brain health ingredient makes European debut |
The first products containing Israeli-based supplier Lipogen’s soy lecithin phosphatidic acid (PA) and phosphatidylserine (PS) combination PS-Plus (PAS) ingredient has been launched in a supplement on the Finnish market. |
|
|||||||||||||||
 |
|
||||||||||||||||
|
|
|||||||||||||||||
|
|
|||||||||||||||||
 |
|
||||||||||||||||
|
|
|||||||||||||||||
 |
|
||||||||||||||||
|
|
|||||||||||||||||
 |
 |
|
|||||||||||||||
|
|
|||||||||||||||||
 |
|
||||||||||||||||
|
|
|||||||||||||||||
 |
|
||||||||||||||||
|
|
|||||||||||||||||
|
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|